BRIP1 coding variants are associated with a high risk of hepatocellular carcinoma occurrence in patients with HCV- or HBV-related liver disease

dc.contributor.authorOussalah, Abderrahim
dc.contributor.authorAVOGBE, PATRICE HODONOU
dc.contributor.authorGuyot, Erwan
dc.contributor.authorChery, Céline
dc.contributor.authorGuéant-Rodriguez, Rosa-Maria
dc.contributor.authorGanne-Carrié, Nathalie
dc.date.accessioned2026-06-02T16:06:57Z
dc.date.available2026-06-02T16:06:57Z
dc.date.issued2016
dc.description.abstractThe molecular mechanisms of hepatocellular carcinoma (HCC) carcinogenesis are still not fully understood. DNA repair defects may in uence HCC risk. The aim of the study was to look for potential genetic variants of DNA repair genes associated with HCC risk among patients with alcohol- or viral-induced liver disease. We performed four case-control studies on 2,006 European- (Derivation#1 and #2 studies) and African-ancestry (Validation#1 and #2 studies) patients originating from several cohorts in order to assess the association between genetic variants on DNA repair genes and HCC risk using a custom array encompassing 94 genes. In the Derivation#1 study, the BRIP1 locus reached array-wide signi cance (Chi-squared SV-Perm, P=5.00×10–4) among the 253 haplotype blocks tested for their association with HCC risk, in patients with viral cirrhosis but not among those with alcoholic cirrhosis. The BRIP1 haplotype block included three exonic variants (rs4986763, rs4986764, rs4986765). The BRIP1 ‘AAA’ haplotype was signi cantly associated with an increased HCC risk [odds ratio (OR), 2.01 (1.19–3.39); false discovery rate (FDR)-P=1.31×10–2]. In the Derivation#2 study, results were con rmed for the BRIP1 ‘GGG’ haplotype [OR, 0.53 (0.36–0.79); FDR-P=3.90×10–3]. In both Validation#1 and #2 studies, BRIP1 ‘AAA’ haplotype was signi cantly associated with an increased risk of HCC [OR, 1.71 (1.09–2.68); FDR-P=7.30×10–2; and OR, 6.45 (4.17–9.99); FDR-P=2.33×10–19, respectively]. Association between the BRIP1 locus and HCC risk suggests that impaired DNA mismatch repair might play a role in liver carcinogenesis, among patients with HCV- or HBV-related liver disease.
dc.identifier.otherBECDB-4126
dc.identifier.urihttps://dspace.uac.bj/handle/123456789/3955
dc.language.isofr
dc.relation.ispartofOncotarget
dc.subjectHepatocellular carcinoma
dc.subjectDNA repair genes
dc.subjectBRIP1
dc.subjectHBV
dc.subjectHCV
dc.titleBRIP1 coding variants are associated with a high risk of hepatocellular carcinoma occurrence in patients with HCV- or HBV-related liver disease
dc.typeArticle

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
584291afefe3095cae05f9e8df0faa3b.pdf
Size:
1.61 MB
Format:
Adobe Portable Document Format

Collections